Stephens Inc Abbott Laboratories Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Stephens Inc holds 114,080 shares of ABT stock, worth $13.2 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

114,080

Previous 118,449 3.69%

Holding current value

$13.2 Million

Previous $12.3 Million 5.67%

% of portfolio

0.19%

Previous 0.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $437,205 - $516,109	-4,369 Reduced 3.69%	114,080 $13 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $402,013 - $448,748	3,991 Added 3.49%	118,449 $12.3 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $562,494 - $621,250	5,136 Added 4.7%	114,458 $13 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $168,745 - $206,558	1,871 Added 1.74%	109,322 $12 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $4.42 Million - $5.3 Million	-46,258 Reduced 30.09%	107,451 $10.4 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $793,944 - $884,620	-7,878 Reduced 4.88%	153,709 $16.8 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $239,050 - $281,376	-2,468 Reduced 1.5%	161,587 $16.4 Million
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $542,792 - $636,779	-5,710 Reduced 3.36%	164,055 $18 Million
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $663,676 - $768,413	-6,859 Reduced 3.88%	169,765 $16.4 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $3.46 Million - $4.18 Million	-33,921 Reduced 16.11%	176,624 $19.2 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $758,575 - $925,033	-6,653 Reduced 3.06%	210,545 $24.9 Million
Q4 2021 Mar 07, 2022	SELL	$115.53 - $141.46 $827,194 - $1.01 Million	-7,160 Reduced 3.19%	217,198 $30.6 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $2.04 Million - $2.25 Million	-17,462 Reduced 7.22%	224,358 $26.5 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $972,421 - $1.14 Million	9,192 Added 3.95%	241,820 $28 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $1.45 Million - $1.71 Million	-13,346 Reduced 5.43%	232,628 $27.9 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $1.81 Million - $1.97 Million	17,234 Added 7.53%	245,974 $26.9 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $1.28 Million - $1.56 Million	-13,993 Reduced 5.76%	228,740 $24.9 Million
Q2 2020 Aug 24, 2020	BUY	$76.57 - $98.0 $977,416 - $1.25 Million	12,765 Added 5.55%	242,733 $22.2 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $2.83 Million - $4.13 Million	44,989 Added 24.32%	229,968 $18.1 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $3.43 Million - $3.82 Million	43,660 Added 30.89%	184,979 $16.1 Million
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $2.05 Million - $2.23 Million	-25,100 Reduced 15.08%	141,319 $11.8 Million
Q2 2019 Aug 01, 2019	BUY	$72.88 - $85.0 $33,816 - $39,440	464 Added 0.28%	166,419 $14 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $334,940 - $404,943	-5,058 Reduced 2.96%	165,955 $13.3 Million
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $32,452 - $36,763	495 Added 0.29%	171,013 $12.4 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $1.59 Million - $1.91 Million	-26,102 Reduced 13.28%	170,518 $12.5 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $519,338 - $573,194	9,021 Added 4.81%	196,620 $12 Million
Q1 2018 May 03, 2018	SELL	$56.27 - $63.62 $142,982 - $161,658	-2,541 Reduced 1.34%	187,599 $11.2 Million
Q4 2017 Feb 05, 2018	SELL	$53.68 - $57.47 $192,013 - $205,570	-3,577 Reduced 1.85%	190,140 $10.9 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $27,250 - $30,413	567 Added 0.29%	193,717 $10.3 Million
Q2 2017 Aug 10, 2017	BUY	N/A	193,150	193,150 $9.39 Million

Others Institutions Holding ABT

# of Institutions

3,177

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account